Articles, Studies and Papers
mRNA vaccine targets cancer
Scientist behind COVID-19 mRNA vaccine says her team’s next target is cancer
Evolutionary Origin of RNA
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification & the Evolutionary Origin of RNA (Katalin Karikó)
mRNA Vaccines Prion Risk?
COVID-19 RNA Based Vaccines and the Risk of Prion Disease [official message: no risk]
Vaccine Deep Vein Thrombosis
Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
mRNA Vaccine Mass Analysis
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Variants vs mRNA Vaccinated
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Bayh-Dole Act Issues
Three areas in Section 202 of the Bayh-Dole Act that require action to ensure sufficient rights in patents on coronavirus relevant inventions
RaDVac SARS-CoV-2 White Paper
RaDVaC White Paper on the SARS-CoV-2 vaccine rationale, design, materials, protocols, and testing.
Coronavirus Spike Proteins
Prefusion Coronavirus Spike Proteins and Their Use by National Institute of Health